Skip to content
Events

Details

Advances in Genome Biology and Technology (AGBT) is considered the preeminent genome science and technology conference where top global researchers, leaders and innovators meet to announce new discoveries, cutting edge breakthroughs and to collaborate. As a recognized cornerstone for the genomics research community, AGBT provides an outstanding forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications. The meeting format includes daytime plenary sessions that feature invited speakers and abstract-selected talks that highlight cutting-edge research across the broad landscape of genomics. The evening concurrent session includes experimental and computational approaches for effectively utilizing the latest DNA sequencing technologies. 

All events below in the Illumina Lounge, Palm Beach unless otherwise indicated.

Tuesday June 7th

8:00 AM

Spotlight Talk: Extending the Reach of Illumina Sequencing Platforms

Fiona Nohilly

Fiona Nohilly
Manager, Product Marketing
Illumina

Joel Fellis

Joel Fellis, PhD
VP Product Management, Sequencing Platforms
Illumina

5:30-7:15 PM: Women’s Networking Event | Signature Island

9:30 PM: CLICK2Win | Sponsor Promenades

 

Wednesday June 8th

8:00 AM

Spotlight Talk: Emerging Applications and Advances in Whole Genome Sequencing

Gary Schroth

Gary Schroth, PhD
VP and Distinguished Scientist
Illumina

Thursday June 9th

8:00 AM

Spotlight Talk: Connecting Samples to Genomic Analysis & Interpretation

Mike Lelivelt

Mike Lelivelt, PhD
VP Product Management, Software & Informatics
Illumina

Product Highlights:
Date & Time
Jun 6, 2022 – Jun 9, 2022
Location
Orlando, Florida
United States
North America
Topic
Instruments, Sequencing reagents & flow cells, Software & informatics

Related Events

Feb 26
Illumina’s Integrated Workflow for Rare and Undiagnosed Genetic Disease Research
Feb 26, 2025
Individuals suspected of having a rare disease often face a long search for an answer. With up to 80% of rare diseases being genetic or having a genetic subtype, it is imperative to interrogate the genome to find answers and shorten the diagnostic odyssey. This webinar provides an overview of the integrated workflow provided by Illumina for rare and undiagnosed diseases research. Starting from library prep to sequencing and informatics, Illumina empowers researchers to find the answers they seek in rare and undiagnosed disease research.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.